# Open Label Immunotherapy of Myoma

> **NCT03550703** · PHASE2 · UNKNOWN · sponsor: **Immunitor LLC** · enrollment: 30 (estimated)

## Conditions studied

- Myoma;Uterus
- Fibroid Uterus
- Leiomyoma
- Fibroma

## Interventions

- **BIOLOGICAL:** V3-Myoma

## Key facts

- **NCT ID:** NCT03550703
- **Lead sponsor:** Immunitor LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03550703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03550703, "Open Label Immunotherapy of Myoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03550703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*